20cm速递 | 创业板医药ETF国泰（159377）上涨1.0%，创新药械景气度获市场关注

Group 1 - The pharmaceutical and biotech sectors are experiencing high growth, with a recommendation for Pharma and Biopharma/Biotech companies that are expected to see a revaluation of their value and performance entering a growth phase [1] - The medical device industry is likely to benefit from policy optimization, as recent statements from relevant authorities indicate support for innovation and a move away from simple lowest-bid procurement practices [1] - The A-share pharmaceutical sector outperformed, with the medical device sub-sector rising by 4.4%, indicating a sustained improvement in industry sentiment [1] Group 2 - The Guotai Medical ETF (159377) tracks the innovative pharmaceutical index (399275), which focuses on companies involved in biotechnology, pharmaceuticals, and related medical services, emphasizing those with high R&D investment and growth potential [1]